CD8A and neoplasm: Another study of melanoma, adoptive transfer of CD8+ cytotoxic T lymphocytes treated with exomiR-23a inhibitor has shown decreased in tumour growth and increased effector function of CD8+ cytotoxic T lymphocytes (Lin et al., 2014).